Search Results 111-120 of 927 for ☂[광고텔레:TOOPPC] 구글카드깡광고 구글찌라시대행 법인통장팝니다 카지노디비광고 개인장팝니다 구글상단도배홍보 상단도배 구글상단도배 신용카드현금화방법 구글웹문서찌라시☂
This study will assess the safety of a new biologic drug, RBX2660 (microbiota suspension) as a treatment for recurrent Clostridium difficile-associated diarrhea ...
About this study. The primary purpose of this study is to collect Biospecimens from patients who developed chemotherapy related cardiac toxicity (CRCT) and ...
Dr. LaRusso holds several U.S. patents for his work in the Cholangiopathies Lab and collaborates with other investigators on liver diseases.
Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With ...
About this study. The goal of the study is to determine if patients undergoing radiofrequency neurotomy of lumbar facet joints that are adjacent to ...
Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism ( ...
About this study. To understand why patients with indigestion with or without diabetes have gastrointestinal symptoms and in particular to understand where ...
The primary purpose of this study is to see how GLPG1690 works together with current standard treatment on lung function and IPF disease in general. The study ...
Research activities within the Department of Molecular Pharmacology and Experimental Therapeutics are affiliated with several other Mayo Clinic research areas:.
About this study. The purpose of this study is to demonstrate 1) feasibility of digital biomarker assessment using wearable in children with solid tumors ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.